DR. JEFFREY S. DOME, MD

Plain English
This study looked at two patients with severe recurrent respiratory papillomatosis (RRP), a condition that causes growths in the airways, and how they responded to a treatment called bevacizumab. After starting this treatment, the patients did not need to go to the hospital for breathing problems, and while some growths remained, they shrank in size and changed shape. This is important because it shows that bevacizumab might be a promising new option for managing severe RRP over the long term. Who this helps: This helps patients with severe recurrent respiratory papillomatosis and their doctors.

Plain English
This research studied the genetic factors that might make children more likely to develop Wilms tumor, a common type of kidney cancer in kids. The researchers looked at 757 children with Wilms tumor and compared them to 1,879 children without it. They found strong links between the tumor and specific genetic markers on chromosomes 2 and 11, showing that mutations in these areas are strongly tied to the risk of developing this cancer. Who this helps: This benefits children at risk for Wilms tumor and their families.

Plain English
This study investigated the role of a small RNA called miR-204 in various cancers, including ovarian, pediatric kidney, and breast cancers. Researchers found that miR-204 is often missing in cancer cells, leading to increased levels of a protein called BDNF, which promotes aggressive cancer behavior. Specifically, when miR-204 is lost, cancer cells can move and invade other tissues more easily due to changes in their structure and signaling pathways. Who this helps: This research benefits cancer patients by highlighting a potential target for new treatments that could prevent the spread of tumors.

Plain English
Researchers studied a type of kidney cancer in children called Wilms' tumor, which occurs in about 1 in 10,000 kids. They found that a specific region on chromosome 2, called 2q37.1, is linked to Wilms' tumor in 4% of the samples they examined from 226 patients. This region may contain a gene that helps prevent tumors from forming, and another molecule, miR-562, which is less active in Wilms' tumors, might be involved in the cancer's development. Who this helps: This research helps doctors better understand the genetic factors behind Wilms' tumor, guiding them in diagnosis and treatment.

Plain English
This study examined models used to test new treatments for childhood cancers, focusing on how closely they match the actual cancers found in patients. Researchers analyzed 87 models and found that they reflected the genetic patterns seen in clinical cancer samples from 112 patients, confirming that the models can be useful for developing new therapies. Specifically, they identified 493 genes with significant genetic changes associated with different cancer types, which had not been reported before. Who this helps: This benefits researchers developing new treatments for children with cancer.

Plain English
This study looked at rhabdoid tumors of the kidney, focusing on how age at diagnosis affects survival rates. Researchers analyzed data from 142 patients and found that young infants (under 6 months) had a very low survival rate of only 8.8%, while older children (2 years and older) had a much better rate of 41.1%. This is crucial because knowing that younger children have worse outcomes can help doctors tailor treatment plans and provide better support to families affected by this aggressive tumor. Who this helps: This helps patients and their families, especially those with young children diagnosed with rhabdoid tumors.

Plain English
Researchers studied the presence of telomerase activity in breast lesions, comparing cases of ductal carcinoma in situ (DCIS) and invasive breast cancer. They found that 70% of both DCIS samples and all invasive cancer samples exhibited detectable telomerase activity. This matters because telomerase activity could help identify which patients with DCIS are at a higher risk of developing invasive breast cancer. Who this helps: This helps patients with DCIS and their doctors in assessing risk and planning treatment.